Serial natriuretic response to atrial peptide in preascitic bile duct ligated dogs

E. Maher, P. Cernacek, M. Levy

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We determined if nine precirrhotic unanaesthetized dogs with chronic bile duct ligation (CBDL) responded uniformly to atrial natriuretic peptide (ANF) by infusing this peptide sequentially over 8-12 weeks at 175 ng·kg-1·min-1 and observing the natriuretic response. ANF was administered every 2 weeks post-CBDL until the 8th week and given again during the cirrhotic phase with ascites present (10-12 weeks post-CBDL). Sodium balance studies were conducted at similar time intervals. During the control period and at weeks, 2, 6, and 8 post-CBDL all dogs responded to ANF with a significant change in sodium excretion (ΔU(Na)V, 50-240 μequiv./min). At these times, all dogs were in sodium balance. At week 4 and during the ascitic period, heterogeneity of response to ANF was observed. In the former interval, five dogs responded (ΔU(Na)V, 75-230 μequiv./min) and four did not, while in the latter interval, five dogs responded (ΔU(Na)V, 50-240 μequiv./min) and three did not (one dog died). In both time periods, there was severe urinary sodium retention (daily U(Na)V, 11 ± 3 and 2 ± 1 mequiv./day, respectively) while the dogs were ingesting 45 mequiv. Na+/day. The heterogeneity of natriuretic response was not correlated to plasma immunoreactive ANF, renin, or aldosterone levels. Plasma volume was significantly expanded from control during both intervals. We conclude that there is transient sodium retention during the 4th week post-CBDL, and that this period is associated with the heterogeneity of natriuretic response to ANF, despite the absence of ascites or edema.

Original languageEnglish (US)
Pages (from-to)1396-1400
Number of pages5
JournalCanadian Journal of Physiology and Pharmacology
Volume68
Issue number11
StatePublished - 1990

Fingerprint

Atrial Natriuretic Factor
Bile Ducts
Dogs
Ligation
Sodium
Ascites
Urinary Retention
Plasma Volume
antiarrhythmic peptide
Aldosterone
Renin
Edema
Peptides

Keywords

  • Cirrhosis
  • Edema
  • Sodium excretion

ASJC Scopus subject areas

  • Physiology
  • Pharmacology

Cite this

Serial natriuretic response to atrial peptide in preascitic bile duct ligated dogs. / Maher, E.; Cernacek, P.; Levy, M.

In: Canadian Journal of Physiology and Pharmacology, Vol. 68, No. 11, 1990, p. 1396-1400.

Research output: Contribution to journalArticle

@article{1b36d3995aae4ed3bba6fbb80451cebb,
title = "Serial natriuretic response to atrial peptide in preascitic bile duct ligated dogs",
abstract = "We determined if nine precirrhotic unanaesthetized dogs with chronic bile duct ligation (CBDL) responded uniformly to atrial natriuretic peptide (ANF) by infusing this peptide sequentially over 8-12 weeks at 175 ng·kg-1·min-1 and observing the natriuretic response. ANF was administered every 2 weeks post-CBDL until the 8th week and given again during the cirrhotic phase with ascites present (10-12 weeks post-CBDL). Sodium balance studies were conducted at similar time intervals. During the control period and at weeks, 2, 6, and 8 post-CBDL all dogs responded to ANF with a significant change in sodium excretion (ΔU(Na)V, 50-240 μequiv./min). At these times, all dogs were in sodium balance. At week 4 and during the ascitic period, heterogeneity of response to ANF was observed. In the former interval, five dogs responded (ΔU(Na)V, 75-230 μequiv./min) and four did not, while in the latter interval, five dogs responded (ΔU(Na)V, 50-240 μequiv./min) and three did not (one dog died). In both time periods, there was severe urinary sodium retention (daily U(Na)V, 11 ± 3 and 2 ± 1 mequiv./day, respectively) while the dogs were ingesting 45 mequiv. Na+/day. The heterogeneity of natriuretic response was not correlated to plasma immunoreactive ANF, renin, or aldosterone levels. Plasma volume was significantly expanded from control during both intervals. We conclude that there is transient sodium retention during the 4th week post-CBDL, and that this period is associated with the heterogeneity of natriuretic response to ANF, despite the absence of ascites or edema.",
keywords = "Cirrhosis, Edema, Sodium excretion",
author = "E. Maher and P. Cernacek and M. Levy",
year = "1990",
language = "English (US)",
volume = "68",
pages = "1396--1400",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "11",

}

TY - JOUR

T1 - Serial natriuretic response to atrial peptide in preascitic bile duct ligated dogs

AU - Maher, E.

AU - Cernacek, P.

AU - Levy, M.

PY - 1990

Y1 - 1990

N2 - We determined if nine precirrhotic unanaesthetized dogs with chronic bile duct ligation (CBDL) responded uniformly to atrial natriuretic peptide (ANF) by infusing this peptide sequentially over 8-12 weeks at 175 ng·kg-1·min-1 and observing the natriuretic response. ANF was administered every 2 weeks post-CBDL until the 8th week and given again during the cirrhotic phase with ascites present (10-12 weeks post-CBDL). Sodium balance studies were conducted at similar time intervals. During the control period and at weeks, 2, 6, and 8 post-CBDL all dogs responded to ANF with a significant change in sodium excretion (ΔU(Na)V, 50-240 μequiv./min). At these times, all dogs were in sodium balance. At week 4 and during the ascitic period, heterogeneity of response to ANF was observed. In the former interval, five dogs responded (ΔU(Na)V, 75-230 μequiv./min) and four did not, while in the latter interval, five dogs responded (ΔU(Na)V, 50-240 μequiv./min) and three did not (one dog died). In both time periods, there was severe urinary sodium retention (daily U(Na)V, 11 ± 3 and 2 ± 1 mequiv./day, respectively) while the dogs were ingesting 45 mequiv. Na+/day. The heterogeneity of natriuretic response was not correlated to plasma immunoreactive ANF, renin, or aldosterone levels. Plasma volume was significantly expanded from control during both intervals. We conclude that there is transient sodium retention during the 4th week post-CBDL, and that this period is associated with the heterogeneity of natriuretic response to ANF, despite the absence of ascites or edema.

AB - We determined if nine precirrhotic unanaesthetized dogs with chronic bile duct ligation (CBDL) responded uniformly to atrial natriuretic peptide (ANF) by infusing this peptide sequentially over 8-12 weeks at 175 ng·kg-1·min-1 and observing the natriuretic response. ANF was administered every 2 weeks post-CBDL until the 8th week and given again during the cirrhotic phase with ascites present (10-12 weeks post-CBDL). Sodium balance studies were conducted at similar time intervals. During the control period and at weeks, 2, 6, and 8 post-CBDL all dogs responded to ANF with a significant change in sodium excretion (ΔU(Na)V, 50-240 μequiv./min). At these times, all dogs were in sodium balance. At week 4 and during the ascitic period, heterogeneity of response to ANF was observed. In the former interval, five dogs responded (ΔU(Na)V, 75-230 μequiv./min) and four did not, while in the latter interval, five dogs responded (ΔU(Na)V, 50-240 μequiv./min) and three did not (one dog died). In both time periods, there was severe urinary sodium retention (daily U(Na)V, 11 ± 3 and 2 ± 1 mequiv./day, respectively) while the dogs were ingesting 45 mequiv. Na+/day. The heterogeneity of natriuretic response was not correlated to plasma immunoreactive ANF, renin, or aldosterone levels. Plasma volume was significantly expanded from control during both intervals. We conclude that there is transient sodium retention during the 4th week post-CBDL, and that this period is associated with the heterogeneity of natriuretic response to ANF, despite the absence of ascites or edema.

KW - Cirrhosis

KW - Edema

KW - Sodium excretion

UR - http://www.scopus.com/inward/record.url?scp=0025615836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025615836&partnerID=8YFLogxK

M3 - Article

C2 - 2149525

AN - SCOPUS:0025615836

VL - 68

SP - 1396

EP - 1400

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 11

ER -